Use access key #2 to skip to page content.

portefeuille (99.62)

biopharma investing

Recs

2

April 28, 2011 – Comments (1)

a post from April 2010.

biotech investing

 

it still works ...

http://caps.fool.com/player/zzlangerhans/sectors.aspx?astable=biotechnology&filter=all#biotechnology

Score: +4,055.12
Accuracy: 80.32%

 

http://caps.fool.com/player/portefeuille/sectors.aspx?astable=biotechnology&filter=all#biotechnology

Score: +4,144.15
Accuracy: 61.94%




 

a few posts by zzlangerhans.

Small cap biotech investing in the era of underperformance

Biotech investing - the Good, the Bad, and the Ugly

Biotech Investing: The Ugly

Ugly lessons in Biotech: Pay attention to interim data from phase III trials

Ugly lessons in biotech: Avoid binary events

Ten Rules of Small Cap Biotech Investing: Lessons From the Ugly

Small cap biotech: The BAD (part I)

Small cap biotech: The BAD (part II)

Small cap biotech: The GOOD (part I)

Small cap biotech: The GOOD (part II)

Small cap biotech: the GOOD (part III)

A question from an Idiot about the S&P comparison

Efficient market? Not in Biotech.

GOOD and BAD Biotechs: One year later

GOOD and BAD Biotechs: One year later (part II)

GOOD and BAD Biotechs: One year later (part III)

Grabbing Bottoms in Miami Beach: A Trader's Manifesto

Two bottoms and a put

GBMB update

Two new bottoms for the GBMB

GBMB update

Two more bottoms for the GBMB

Back in the GBMB hunt

Carnival Bottoms

More bottoms for the grabbing

The GBMB in review, part I

The GBMB in review, part II

The GBMB in review, part III

1 Comments – Post Your Own

#1) On April 28, 2011 at 5:06 PM, portefeuille (99.62) wrote:

and don't listen to "caps" game players that use book value and revenue of development stage "baby biotech" companies as their primary guideline, hehe (just kidding) ...

Report this comment

Featured Broker Partners


Advertisement